Bafna Pharmaceuticals Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting
29-05-2026 | 06:31 pm
29-05-2026 | 06:31 pm
Bafna Pharma's Board approved Q4 FY26 and full-year financial results. The company reported a profit of ₹2.75 Cr for Q4 and ₹11.00 Cr for the full year ended March 31, 2026.
No comments yet. Be the first to comment!
